Patients with MS are specifically vulnerable to the neuropsychiatric impacts of the COVID-19 pandemic. About 70% of multiple sclerosis patients suffer from cognitive dysfunction. This affects information processing and impacts episodic memory. Depression and anxiety result in a lower quality of life, increased fatigue and disability scores, and a more aggressive MS course. Studies show that depression impacts cognition and anxiety worsens the patient's verbal learning.